Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,940 total articles
Fossil has stabilized around the mid-$5s after a prolonged restructuring and debt overhaul. Reduced promotional activity, inclusion in the Russell 2000 and a possible India IPO create a credible path for earnings recovery and multiple expansion. This trade targets a move toward $8 over the next 180 trading days with a disciplined stop below $4.40.
Taiwan Semiconductor (TSM) remains the backbone of the AI semiconductor supply chain. With a $2.16T market cap, ~72-73% share of third-party foundry spending, and customers (notably Nvidia) driving outsized demand, TSM is positioned to benefit as hyperscalers and cloud players scale custom silicon. This is a measured long trade: enter near $415.70,…
Immunic's oral immunology pipeline — anchored by vidofludimus calcium and supported by IMU-935 and IMU-856 — looks primed for renewed market attention. At $16.78, the stock trades closer to a cash-adjusted enterprise value than to a growth-stage peer multiple. With compelling technicals, compressed float and upcoming catalysts, this is a tactical l…
Alibaba is digesting heavy AI capex and a pullback in China e-commerce, but cloud revenue growing 45% and a market cap of ~$298B leave room for upside. This trade targets a rebound to $150 with a strict $102 stop and a mid-term horizon of 45 trading days.
Philip Morris (PM) is a global tobacco incumbent with heavy exposure to higher-growth smoke-free products and a reliable ~$12.7B annual free cash flow stream. The stock trades at a premium (P/E ~27.5, P/FCF ~23.5) but carries a 3%+ dividend and bullish technicals. This trade idea is a mid-term (45 trading days) swing long to $215 with a $178 stop—a…
SK hynix is positioned to benefit if bespoke HBM (high-bandwidth memory) stacks become the differentiator in generative AI hardware. This trade idea argues that a string of design wins and better ASPs over the next several quarters could re-rate the stock. Entry, stop and target provided with a clear risk framework and catalysts to watch.
Bloom Energy (BE) remains my top pick in the fuel-cell / data-center power niche. Recent results, a factory-driven installation system and robust guidance have prompted sell-side upgrades and renewed investor interest. I reiterate Buy with a defined mid-term trade: enter near $215, stop at $175, target $300 over ~45 trading days. The setup offers a…
Transportadora de Gas del Sur (TGS) is positioned to convert Argentina's shale expansion into steady volume and EBITDA growth. The stock trades at a reasonable multiple against a $4.49B market cap and offers a clear risk-reward as infrastructure projects and service-line diversification begin to deliver. This trade targets appreciation over the nex…
Alibaba's recent pullback has priced in AI capex and e-commerce softness. With cloud revenue climbing 45% and a market cap of ~$298B, this trade idea recommends a mid-term long while the market discounts AI spend and litigation noise.
Shares of Fiserv plunged amid CEO turnover, activist pressure and refinancing noise. The market's reaction looks disproportionate relative to a business that still generates nearly $4.0B in free cash flow, trades at ~10x earnings and has an enterprise value to EBITDA of ~7.2x. This trade idea lays out an actionable long with an entry, stop and targ…
Western Digital plunged after a strong quarter and aggressive guidance refresh, handing patient traders an opportunity. Fundamentals show high revenue growth, robust free cash flow and a reasonable P/E versus the froth in NAND names. This trade idea lays out an entry at $435.25, stop at $380.00 and primary target at $520.00 over a mid-term 45 tradi…
Ondas (ONDS) looks poised to move past a temporary hit to cash and execution risk from the Cyberhawk acquisition. With a $4.69B market cap, heavy order flow, and improving revenue trajectory, the trade here is a long with a clear entry at $8.00, a stop at $6.50 and a primary target of $13.00 over a 180-trading-day horizon.
Sandisk is sitting on locked-in contract revenue, severe supply constraints for high-bandwidth memory, and cash generation that together make an 80% margin outcome plausible. This is an actionable long: enter at $1520.20, stop at $1350.00, target $1950.00 over a 180 trading day horizon. High-risk trade but asymmetric reward if AI-driven memory tigh…
REGENXBIO (RGNX) plunged after an FDA clinical hold tied to RGX-111. The sell-off has compressed the price to $8.40 with technically oversold readings and a market cap near $555M. This idea outlines a high-risk, mid-term swing long with a tight stop to limit downside while targeting mean-reversion toward the mid-teens if catalysts align.
Shurgard Self Storage offers a concentrated portfolio of urban storage assets across high-rent European cities. The company is trading at a material discount to what underlying land and development replacement costs imply. This trade proposes a long position with a clear entry, stop and target and a 180 trading day horizon to capture both operation…
Cousins Properties (CUZ) continues to show durability in Class A Sunbelt office markets. The REIT trades near book value with a ~4.3% yield, manageable leverage and improving leasing indicators. For patient, income-oriented investors, CUZ is a buy with a clear entry, stop and target over a 180-trading-day horizon.
Datadog is benefitting from AI-driven demand for observability and security at scale. Growth is accelerating in recent quarters, free cash flow is solid, and institutional interest is visible. Valuation is rich, so this is a tactical swing trade: buy on a pullback, manage risk via a defined stop, and target a near-term re-rating if revenue accelera…
Oracle is trading at $144.53 after a dramatic re-rating from last year's peak. A company investor update scheduled for 09/10/2026 is the next big catalyst; beat and address cash-flow concerns and the stock can trend sharply higher, miss or underwhelm and downside will accelerate. This trade idea lays out an actionable mid-term long with exact entry…
Alphabet remains one of the cleanest ways to own the AI-driven re-acceleration of digital advertising and cloud infrastructure. With a market cap north of $4.25 trillion, a mid-teens P/E, $53.3 billion in free cash flow and healthy balance-sheet metrics, the company can both invest aggressively in AI and return capital to shareholders. This trade t…
Nasdaq is positioned to monetize 23-hour trading and expanding global market infrastructure. The stock trades at roughly $98 and offers a way to play durable fee growth, high free cash flow, and product expansion. This trade favors a long entry at $98.18 with a $120 target over a 180-trading-day horizon and a $88 stop to protect against regulatory …
Darovasertib's positive Phase 2/3 metastatic uveal melanoma data and an impending FDA filing materially reduce program risk for IDEAYA while creating optionality across its precision-oncology pipeline. With nearly $1.0 billion in reported cash and a market cap near $4.0 billion, IDYA is a buy for disciplined long-term traders who accept biotech bin…
Stride (LRN) is trading below where fundamentals justify. With trailing EPS of $8.14, free cash flow of $433M and an enterprise value roughly in line with cash generation, the stock appears to underprice a normalized growth and margin recovery. This trade targets a re-rating as implementation headwinds fade and enrollment wins and product traction …
Nano Labs is a high-throughput and vision-chip designer trading at a sub-$50M market cap. Recent AI infrastructure partnerships and product pushes give a clear rerating route; the company’s cheap multiples, bullish technicals and elevated short interest create an asymmetric risk/reward for a selective long position over a 180-trading-day horizon.
Astera Labs is a high-quality play on AI data center connectivity: strong top-line growth, 25%+ margins, zero debt and healthy free cash flow. The stock is volatile and richly valued, but recent technical weakness offers a measured entry for a long-term trade that captures continued rack-scale AI adoption and multiple expansion if execution stays c…
Regeneron ($REGN) has bounced back from a headline-driven drawdown but the setup remains constructive. At $829.48, the stock trades at ~20x trailing earnings with a free cash flow yield near 4.4% and low leverage. This trade idea outlines an actionable entry, stop, and target with a mid-term horizon, and highlights catalysts and risks tied to pipel…
